The PARIS Test prescreens a broad panel of cancer drugs in patient-derived live tumor cells and provides actionable results 70% of the time, on average.
It was revealed this week by the Biden Administration that there will be an additional $1 billion to help manufacturers keep up with the soaring demand for COVID-19-related diagnostics.
Medtech analysts share insights for one of their most frequently asked about companies.
A cybersecurity expert weighs in on the recent Facebook outage, and how medical device companies (and others) can avoid the same mistake.
A new system developed by researchers from the University of Bern, combines optical and electrical recording of cardiac ventricular activation.
The Marlborough, MA-based company said it has signed an agreement to acquire Baylis Medical for $1.75 billion.
Unpacking two similar, but separate, recalls involving Medtronic MiniMed insulin pumps.
There are a lot of factors driving the demand for COVID-19 rapid tests. But can a newly authorized diagnostic help make a difference?
A medtech analyst shares insights for one of his most frequently asked about companies.
